Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Oncogene

• Publication date

  2005-04-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1208447PMID 15735737
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multiple myeloma.

  2018cited by this paper
• Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses

  2005influential reference
• Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma.

  2004cited by this paper
• Regulation of CX3CL1/fractalkine expression in endothelial cells.

  2004cited by this paper
• Advances in biology of multiple myeloma: clinical applications.

  2004cited by this paper
• Correlation of TACC3, FGFR3, MMSET and p21 expression with the t(4;14)(p16·3;q32) in multiple myeloma

  2004cited by this paper
• Bone lesions in molecular subtypes of multiple myeloma.

  2004cited by this paper
• A Global Expression-based Analysis of the Consequences of the t(4;14) Translocation in Myeloma

  2004cited by this paper
• Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis.

  2003influential reference
• Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell development.

  2003influential reference
• ARK5 suppresses the cell death induced by nutrient starvation and death receptors via inhibition of caspase 8 activation, but not by chemotherapeutic agents or UV irradiation

  2003cited by this paper
• Genomic targets of the human c-Myc protein.

  2003cited by this paper
• New insights into the pathophysiology of multiple myeloma.

  2003cited by this paper
• The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma.

  2003cited by this paper
• In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression.

  2003cited by this paper
• Occurrence of dysregulated oncogenes in primary plasma cells representing consecutive stages of myeloma pathogenesis: indications for different disease entities

  2003cited by this paper
• Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients.

  2002cited by this paper
• Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays

  2002influential reference
• Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy.

  2002cited by this paper
• GADD45-induced cell cycle G2-M arrest associates with altered subcellular distribution of cyclin B1 and is independent of p38 kinase activity

  2002influential reference
• The biology and cytogenetics of multiple myeloma.

  2002cited by this paper
• Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells.

  2002influential reference
• Methods for assessing reproducibility of clustering patterns observed in analyses of microarray data

  2002cited by this paper
• Protein Binding and Functional Characterization of Plakophilin 2

  2002cited by this paper
• Clinicopathological and prognostic characteristics of CD56‐negative multiple myeloma

  2002cited by this paper
• Gene Expression Profiling of B Cell Chronic Lymphocytic Leukemia Reveals a Homogeneous Phenotype Related to Memory B Cells

  2001cited by this paper
• Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myeloma.

  2001cited by this paper
• Feature extraction and normalization algorithms for high‐density oligonucleotide gene expression array data

  2001cited by this paper
• Ectopic Expression of MAFB Gene in Human Myeloma Cells Carrying (14;20)(q32;q11) Chromosomal Translocations

  2001cited by this paper
• Chromosome translocations in multiple myeloma

  2001cited by this paper
• A unique mRNA initiated within a middle intron of WHSC1/MMSET encodes a DNA binding protein that suppresses human IL-5 transcription.

  2001cited by this paper
• Krüppel-like Factor 4 (Gut-enriched Krüppel-like Factor) Inhibits Cell Proliferation by Blocking G1/S Progression of the Cell Cycle*

  2001cited by this paper
• SPLASH: structural pattern localization analysis by sequential histograms

  2000cited by this paper
• The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cells.

  2000cited by this paper
• NADE, a p75NTR-associated Cell Death Executor, Is Involved in Signal Transduction Mediated by the Common Neurotrophin Receptor p75NTR*

  2000cited by this paper
• Toll-like receptors in the induction of the innate immune response

  2000cited by this paper
• Gut-enriched Krüppel-like factor represses cyclin D1 promoter activity through Sp1 motif.

  2000cited by this paper
• Genes encoding tumor-specific antigens are expressed in human myeloma cells.

  1999cited by this paper
• Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells.

  1999cited by this paper
• Molecular analysis of 11q13 breakpoints in multiple myeloma.

  1999cited by this paper
• Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma.

  1998cited by this paper
• The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts.

  1998cited by this paper
• Cluster analysis and display of genome-wide expression patterns.

  1998cited by this paper
• A novel chromosomal translocation t(4; 14)(p16.3; q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene.

  1997cited by this paper
• Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3

  1997cited by this paper
• Real time quantitative PCR.

  1996cited by this paper
• Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines.

  1996cited by this paper
• Cold shock domain proteins repress transcription from the GM-CSF promoter.

  1996cited by this paper
• Distinct Xp11.2 breakpoint regions in synovial sarcoma revealed by metaphase and interphase FISH: relationship to histologic subtypes.

  1994cited by this paper
• A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

  1975cited by this paper

• Dual targeting of G9a and DNMTs induces antitumor effects in multiple myeloma

  2025cites this paper
• Multi-omics profiling and AI-driven clinically deployable risk models in MGUS and smoldering myeloma

  2025cites this paper
• Downregulated expression of dual-specificity phosphatase-1 in multiple myeloma as a predictor of poor survival outcomes

  2025cites this paper
• Molecular Signatures of CB-6644 Inhibition of the RUVBL1/2 Complex in Multiple Myeloma

  2024cites this paper
• Investigating the effect of immunomagnetic separation on the immunophenotype and viability of plasma cells in plasma cell disorders

  2024cites this paper
• PVT1 interacts with polycomb repressive complex 2 to suppress genomic regions with pro-apoptotic and tumour suppressor functions in multiple myeloma

  2023cites this paper
• The role and regulation of Maf proteins in cancer

  2023influential citation
• Simultaneous XIAP and cIAP1/2 inhibition by a dimeric SMAC mimetic AZD5582 induces apoptosis in multiple myeloma.

  2023cites this paper
• BET in hematologic tumors: Immunity, pathogenesis, clinical trials and drug combinations

  2022cites this paper
• Discovery of the oncogenic MDM2, a direct binding target of berberine and a potential therapeutic, in multiple myeloma

  2022cites this paper
• Applications of noncoding ribonucleic acids in multiple myeloma patients

  2022cites this paper
• Metabolic Vulnerabilities in Multiple Myeloma

  2022cites this paper
• Benchmark Dose Modeling Approaches for Volatile Organic Chemicals using a Novel Air-Liquid Interface In Vitro Exposure System.

  2022cites this paper
• Downregulation of ITGA6 confers to the invasion of multiple myeloma and promotes progression to plasma cell leukaemia

  2021cites this paper
• A distinct metabolic response characterizes sensitivity to EZH2 inhibition in multiple myeloma

  2021cites this paper
• DDX10 promotes the proliferation and metastasis of colorectal cancer cells via splicing RPL35

  2021cites this paper
• Transcriptomic Analysis in Multiple Myeloma and Primary Plasma Cell Leukemia with t(11;14) Reveals Different Expression Patterns with Biological Implications in Venetoclax Sensitivity

  2021cites this paper
• Functional Impact of Genomic Complexity on the Transcriptome of Multiple Myeloma

  2021cites this paper
• IDH2 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in multiple myeloma

  2021cites this paper
• Metabolic Effects of Recurrent Genetic Aberrations in Multiple Myeloma

  2021cites this paper
• Tumour Dissemination in Multiple Myeloma Disease Progression and Relapse: A Potential Therapeutic Target in High-Risk Myeloma

  2020influential citation
• A Journey Through Myeloma Evolution: From the Normal Plasma Cell to Disease Complexity

  2020cites this paper
• Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myeloma.

  2020cites this paper
• HLA-DPA1 gene is a potential predictor with prognostic values in multiple myeloma

  2020cites this paper
• Meta-Analysis of Transcriptomic Data of Dorsolateral Prefrontal Cortex and of Peripheral Blood Mononuclear Cells Identifies Altered Pathways in Schizophrenia

  2020cites this paper
• Targeting of the E3 ubiquitin-protein ligase HUWE1 impairs DNA repair capacity and tumor growth in preclinical multiple myeloma models

  2020cites this paper
• COPZ1 depletion in thyroid tumor cells triggers type I IFN response and immunogenic cell death.

  2020cites this paper
• Prognostic role of minichromosome maintenance family in multiple myeloma

  2020cites this paper
• Transcriptome analysis reveals significant differences between primary plasma cell leukemia and multiple myeloma even when sharing a similar genetic background

  2019cites this paper
• Expanding the repertoire of miRNAs and miRNA-offset RNAs expressed in multiple myeloma by small RNA deep sequencing

  2019cites this paper
• THE RELEVANCE OF LONG NON-CODING RNA IN THE BIOLOGICAL AND CLINICAL HETEROGENEITY OF MULTIPLE MYELOMA

  2019cites this paper
• Roles of DDX5 in the tumorigenesis, proliferation, differentiation, metastasis and pathway regulation of human malignancies.

  2019cites this paper
• A multiple myeloma classification system that associates normal B-cell subset phenotypes with prognosis.

  2018cites this paper
• In silico analysis identifies CRISP3 as a potential peripheral blood biomarker for multiple myeloma: From data modeling to validation with RT-PCR.

  2018cites this paper
• MOLECULAR HETEROGENEITY OF MULTIPLE MYELOMA: THE BIOLOGICAL AND CLINICAL RELEVANCE OF NOVEL GENE MUTATIONS BY NEXT GENERATION SEQUENCING

  2018cites this paper
• Global methylation patterns in primary plasma cell leukemia.

  2018cites this paper
• Hypoxia-inducible KDM3A addiction in multiple myeloma.

  2018cites this paper
• A compendium of long non-coding RNAs transcriptional fingerprint in multiple myeloma

  2018cites this paper
• Hypoxia‐inducible microRNA‐210 regulates the DIMT1‐IRF4 oncogenic axis in multiple myeloma

  2017cites this paper
• Polyclonal Immunoglobulin G N-Glycosylation in the Pathogenesis of Plasma Cell Disorders.

  2017cites this paper
• Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myeloma

  2016cites this paper
• Molecular spectrum of TP53 mutations in plasma cell dyscrasias by next generation sequencing: an Italian cohort study and overview of the literature

  2016cites this paper
• MAF protein mediates innate resistance to proteasome inhibition therapy in multiple myeloma.

  2016cites this paper
• Molecular Classification and Pharmacogenetics of Primary Plasma Cell Leukemia: An Initial Approach toward Precision Medicine

  2015cites this paper
• Disentangling the microRNA regulatory milieu in multiple myeloma: integrative genomics analysis outlines mixed miRNA-TF circuits and pathway-derived networks modulated in t(4;14) patients

  2015cites this paper
• A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias

  2015cites this paper
• Plasma cell morphology in multiple myeloma and related disorders.

  2015cites this paper
• Molecular Biology of Multiple Myeloma

  2015influential citation
• Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias: implication for MEK-ERK pathway activation

  2015cites this paper
• KLF4-SQSTM1/p62-associated prosurvival autophagy contributes to carfilzomib resistance in multiple myeloma models

  2015cites this paper
• Whole-exome sequencing of primary plasma cell leukemia discloses heterogeneous mutational patterns

  2015cites this paper
• Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies

  2014influential citation
• CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications

  2014cites this paper
• Gene set enrichment analysis of the NF-κB/Snail/YY1/RKIP circuitry in multiple myeloma

  2014cites this paper
• MicroRNA: Important Player in the Pathobiology of Multiple Myeloma

  2014cites this paper
• Transcriptional Characterization of a Prospective Series of Primary Plasma Cell Leukemia Revealed Signatures Associated with Tumor Progression and Poorer Outcome

  2013cites this paper
• Genome‐wide analysis of primary plasma cell leukemia identifies recurrent imbalances associated with changes in transcriptional profiles

  2013cites this paper
• Single-agent Smac-mimetic compounds induce apoptosis in B chronic lymphocytic leukaemia (B-CLL).

  2013cites this paper
• Aspects biologiques de l'angiogenèse dans le myélome multiple

  2013cites this paper
• Progression and Poorer Outcome Plasma Cell Leukemia Revealed Signatures Associated with Tumor Transcriptional Characterization of a Prospective Series of Primary

  2013cites this paper
• The Genomics of Multiple Myeloma and Its Relevance in the Molecular Classification and Risk Stratification of the Disease

  2013cites this paper
• Advances in Multiple Myeloma Gene-Expression Profiling

  2013cites this paper
• Molecular profiling of multiple myeloma: from gene expression analysis to next-generation sequencing

  2013cites this paper
• Signalling Molecules as Selective Targets for Therapeutic Strategies in Multiple Myeloma

  2012cites this paper
• Molecular and Cellular Effects of NEDD8-Activating Enzyme Inhibition in Myeloma

  2012cites this paper
• An intermediate-risk multiple myeloma subgroup is defined by sIL-6r: levels synergistically increase with incidence of SNP rs2228145 and 1q21 amplification.

  2012cites this paper
• MicroRNAs in the pathobiology of multiple myeloma.

  2012cites this paper
• The expression pattern of small nucleolar and small Cajal body-specific RNAs characterizes distinct molecular subtypes of multiple myeloma

  2012cites this paper
• Clinical utility and implementation of gene-expression profiling in myeloma: current status and challenges

  2012cites this paper
• Preclinical Development Molecular and Cellular Effects of NEDD 8-Activating Enzyme Inhibition in Myeloma

  2012cites this paper
• SCFFbxo9 and CK2 direct the cellular response to growth factor withdrawal via Tel2/Tti1 degradation and promote survival in multiple myeloma

  2012cites this paper
• BET bromodomain inhibition as a therapeutic strategy to target c-Myc.

  2011influential citation
• Microenvironmental Influence on Pre-Clinical Activity of Polo-Like Kinase Inhibition in Multiple Myeloma: Implications for Clinical Translation

  2011cites this paper
• The type III transforming growth factor-β receptor inhibits proliferation, migration, and adhesion in human myeloma cells

  2011influential citation
• Biological aspects of angiogenesis in multiple myeloma

  2011cites this paper
• Genomic profiling of enzastaurin‐treated B cell lymphoma RL cells

  2011cites this paper
• MAFA (v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (avian))

  2011cites this paper
• Distinct transcriptional profiles characterize bone microenvironment mesenchymal cells rather than osteoblasts in relationship with multiple myeloma bone disease.

  2010cites this paper
• Pleiotropic anti-myeloma activity of ITF2357: inhibition of interleukin-6 receptor signaling and repression of miR-19a and miR-19b

  2010cites this paper
• Retrospective case series of three patients with plasma cell leukemia treated with bortezomib-based regimens.

  2010cites this paper
• Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells

  2010cites this paper
• Bone morphogenetic proteins and receptors are over-expressed in bone-marrow cells of multiple myeloma patients and support myeloma cells by inducing ID genes

  2010cites this paper
• Adhesive Interactions Regulate Transcriptional Diversity in Malignant B Cells

  2010cites this paper
• The clinical and biological features of a series of immunophenotypic variant of B‐CLL

  2010cites this paper
• Polycomb Target Genes Are Silenced in Multiple Myeloma

  2010cites this paper
• Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms.

  2010cites this paper
• Tumorigenesis and Neoplastic Progression Iron-Dependent Regulation of MDM2 Influences p53 Activity and Hepatic Carcinogenesis

  2010cites this paper
• Bone morphogenetic proteins and receptors are over-expressed in bone-marrow cells of multiple myeloma patients and support myeloma cells by inducing ID genes.

  2010cites this paper
• Adhesion molecules--The lifelines of multiple myeloma cells.

  2010cites this paper
• A SNP microarray and FISH‐based procedure to detect allelic imbalances in multiple myeloma: An integrated genomics approach reveals a wide gene dosage effect

  2009cites this paper
• Characterization of c-Maf transcription factor in normal and neoplastic hematolymphoid tissue and its relevance in plasma cell neoplasia.

  2009cites this paper
• Differential repetitive DNA methylation in multiple myeloma molecular subgroups.

  2009cites this paper
• Gene Expression Profiling of Bone Marrow Endothelial Cells in Patients with Multiple Myeloma

  2009cites this paper
• Concomitant downregulation of proliferation/survival pathways dependent on FGF-R3, JAK2 and BCMA in human multiple myeloma cells by multi-kinase targeting.

  2009cites this paper
• Chapter 25 – Molecular Hematopathology

  2009cites this paper
• Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma.

  2009cites this paper
• Pleiotropic anti-myeloma activity of ITF 2357 : inhibition of IL-6 receptor signalling and repression of miR-19 a and miR-19 b by

  2009cites this paper
• The molecular characterization and clinical management of multiple myeloma in the post-genome era

  2009cites this paper
• SPOTLIGHT REVIEW The molecular characterization and clinical management of multiple myeloma in the post-genome era

  2009cites this paper
• Integrative high‐resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles

  2009cites this paper